In our study, we validated that the combination of syrosingopine and UK-5099 activated a sustained activation of the ISR through HRI kinase, leading to the apoptosis of NSCLC cells and inhibition of their proliferation. The gene discussed is EIF2AK1; the disease is non-small cell lung carcinoma.